ReviewTranslational breast cancer research : a journal focusing on translational research in breast cancer2022

Thoughts on therapy strategy in the era of "after anti-HER2 TKI" in CSCO BC Guidelines 2022.

Li Bian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.